Relationship Between Health Risk and Occupational Exposure of ED
Launched by SAMSUNG MEDICAL CENTER · Dec 6, 2022
Trial Information
Current as of January 13, 2025
Unknown status
Keywords
ClinConnect Summary
Background : In South Korea, incidence of medical emergency is increasing, and 10 million people are using emergency medical services annually. Emergency medical services, which are directly related to the lives of the people, are essential, but medical staffs engaged in the department are reported to be at high risk due to health-related problems and poor working conditions. Although their general health status is confirmed through periodical health screening, there is a lack of research regarding each really individual health problems.
Objective : This study aims to establish a sub-cohor...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • An Emergency Medical Worker (doctor, nurse) subject recruited from prior cohort construction studies.
- • An adult aged 18 or older, who voluntarily agrees and signs.
- • A subject who has not experienced occupational disease or damage within four weeks from the time of establishing a sub-cohort.
- Exclusion Criteria:
- • An subject who was recruited from prior cohort construction studies, but withdraws the agrees at the time of establishing a sub-cohort
- • A subject who does not agree to participate in this study or withdraw the consent after agreement.
- • A subject who is not engaged in work, such as leave of absence.
- • A subject who has experienced occupational disease or damage within four weeks from the time of establishing a sub-cohort.
- • A subject who is legally unable to participate in clinical research or unable to participate in clinical research at the discretion of the investigator.
Trial Officials
Taerim Kim
Principal Investigator
Samsung Medical Center
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials